CoronaVac: A review of efficacy, safety, and immunogenicity of the inactivated vaccine against SARS-CoV-2

CoronaVac, also known as the Sinovac inactivated SARS-CoV-2 vaccine, has been widely implemented in combating the COVID-19 pandemic. We summarized the results of clinical trials and real-world studies of CoronaVac in this review. The overall efficacy for the prevention of symptomatic COVID-19 (befor...

Descripción completa

Detalles Bibliográficos
Autores principales: Jin, Lairun, Li, Zhuopei, Zhang, Xiaoyin, Li, Jingxin, Zhu, Fengcai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Coronavirus – Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746539/
https://www.ncbi.nlm.nih.gov/pubmed/35878789
http://dx.doi.org/10.1080/21645515.2022.2096970

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746539/
https://www.ncbi.nlm.nih.gov/pubmed/35878789
http://dx.doi.org/10.1080/21645515.2022.2096970

Ejemplares similares